FindTrial
Sign In

A clinical Trial of Mukhakantiprada lepa and its cream on human patients of hyperpigmentation on face

Pharmaceutico-analytical study and randomized controlled clinical trial of modified mukhakantiprada lepa in vyanga

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/019385
Enrollment
60
Registered
2019-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L81- Other disorders of pigmentation

Interventions

Intervention1: Modified form of lepa in the form of cream: Cream will be applied on affected part on face once in a day. Concentration of cream will be 33.33% w/w. Dose-As required as it is depended o

Sponsors

Sane guruji Arogya kendra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient showing signs and symptoms of vyanga as per classical text like Niruja(painless),Mandala(round patch),Shyava(blotchy brown pigmentation) on face

Exclusion criteria

Exclusion criteria: 1.Birth mark 2.Any known facial injuries with scares 3.Hormonal therapy and patient with systemic disorders. 4.Patients on any other medication for the same problem during the study 5.Pregnant ladies

Design outcomes

Primary

MeasureTime frame
1. Colour of lesion(patch)Timepoint: 30 days—

Secondary

MeasureTime frame
1.Number of lesions(patch) 2.Size of lesion(patch) 2.Size of lesion(patch) 3.Colour of lesion(patch)Timepoint: 30 days—

Countries

India

Contacts

Public ContactRicha Arvind Agrawal

Maharashtra university of Health Sciences,Nashik

jbgavali@gmail.com7709819535

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026